LSIPR 50 2017: Tim Haines


Tim Haines was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

Name: Tim Haines 

Organisation: Abingworth 

Position: Managing partner

LSIPR 2017, Tim Haines, Abingworth, investment, life sciences, healthcare, CRISPR, CRISPR Therapeutics, biopharma, gene-editing